All Infectious Disease articles – Page 9
-
NewsLow vitamin D levels shown to raise risk of hospitalization with potentially fatal respiratory tract infections by 33%
Severe vitamin D deficiency is associated with a higher rate of hospitalisation for respiratory tract infections such as bronchitis and pneumonia. Scientists found that those with a severe deficiency (below 15 nnmol/L) were 33 per cent more likely to be admitted to hospital for treatment.
-
NewsMajor clinical trial provides definitive evidence of impacts of steroid treatment on severe brain infection
A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for encephalitis, caused by herpes simplex virus (HSV) does not improve long-term outcomes overall, although early use may lead to better recovery.
-
NewsOral bacterium may promote breast cancer development and spread
Researchers found that Fusobacterium nucleatum, an oral bacterium commonly associated with periodontal disease, can promote breast cancer initiation, tumor growth and spread by inducing DNA damage and altering cancer cell behavior.
-
NewsResearch team identifies species of brucellosis-causing bacteria in Cameroon
Researchers have identified the specific species of the Brucella bacterium that causes illness in animals in Cameroon. A study of more than 4,600 livestock animals found that the only Brucella species present was Brucella abortus, a species primarily associated with cattle that causes pregnancy loss and infertility.
-
NewsScientists discover novel immune ‘traffic controller’ hijacked by virus
Researchers have discovered a tissue protein that acts as a central ‘traffic controller’ for immune cells and can be hijacked by a virus to weaken immune responses. Cytomegalovirus (CMV) can hijack this system by producing a protein that blocks CD44 function on stromal cells.
-
NewsMost would recommend RSV immunizations for older and pregnant people
A US survey found an increase in awareness of immunizations that are available for RSV. The survey of 1,637 U.S. adults also found that about 6 in 10 respondents would recommend the vaccine or antibody injections to the groups recommended by the CDC, an increase from past years.
-
CareersThe National Collection of Pathogenic Viruses (NCPV): a critical resource for virology and public health
It’s now 25 years since the National Collection of Pathogenic Viruses (NCPV) was founded as a dedicated, secure, and relevant national virus repository for the UK. Jane Burton, Teresa Ramalho and Tilly Maybery explore how the collection has evolved - and is tackling future global health concerns.
-
NewsEarly translational study supports the role of high-dose inhaled nitric oxide as a potential antimicrobial therapy
Researchers report that high-dose inhaled nitric oxide (iNO) demonstrates potential antimicrobial activity in preclinical models and is safe and feasible in early human studies, supporting further clinical investigation.
-
NewsEngineered nanobodies improved respiratory defenses in preclinical study
Engineered nanobodies improved protection against multiple viruses by bolstering respiratory mucus. The bispecific design of the nanobodies works against viruses, like influenza, which can normally evade mucosal defenses.
-
NewsThe brain’s sneakiest houseguest: how a parasite rewrites neuron messages and alters neuroplasticity
A new study describes how Toxoplasma gondii manipulates the behaviour and brain function of its hosts. It explored a new angle by looking at nanoparticles called extracellular vesicles, which cells use to send messages to one another, and carry small regulatory molecules known as microRNAs.
-
NewsNew study shows how light suppresses virulence in antibiotic-resistant pathogen
Researchers uncover a light-sensitive signaling cascade in Pseudomonas aeruginosa that suppresses biofilm formation and virulence, offering a potential new strategy to combat antibiotic-resistant infections.
-
NewsSeawater microbes offer new, non-invasive way to detect coral disease, study finds
Researchers have discovered that microorganisms in seawater surrounding corals provide a powerful indicator of coral disease, potentially transforming how reef health is monitored worldwide.
-
NewsGlobal Virus Network warns of measles resurgence
The Global Virus Network (GVN) has expressed deep concern regarding the ongoing resurgence of measles in the United States and around the globe. Measles is one of the most contagious viral diseases known and can be lethal, particularly in unvaccinated children.
-
NewsPaper sheds light on human impact of first known ancient pandemic
A new paper examines the Plague of Justinian and its consequences for ancient Jordan. Focusing on the first-known outbreak of bubonic plague in the Mediterranean world, it adds to the historical record on what caused the devastating outbreak that killed millions within the Byzantine Empire.
-
NewsHidden mpox exposure detected in healthy Nigerian adults, revealing under-recognized transmission
The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically associated with the disease, according to new research.
-
NewsHuman nasal passages defend against the common cold and help determine how sick we get
Researchers demonstrate how the cells in our noses work together to defend us from the common cold and suggest that our body’s defense to rhinovirus—not the virus itself—typically predicts whether or not we catch a cold, as well as how bad our symptoms will be.
-
NewsGolden Gate method enables rapid, fully-synthetic engineering of therapeutically relevant bacteriophages
Researchers have described the first fully synthetic bacteriophage engineering system for Pseudomonas aeruginosa. In this method, researchers engineer bacteriophages synthetically using sequence data rather than bacteriophage isolates.
-
NewsValneva provides update on Chikungunya vaccine IXCHIQ®
Valneva SE has announced that the company has decided to voluntarily withdraw the biologics license application (BLA) and Investigational New Drug (IND) application for its chikungunya vaccine, IXCHIQ® , in the United States, following suspension of the license by the FDA.
-
NewsShingles vaccine linked to slower biological aging in older adults
Shingles vaccination not only protects against the disease but may also contribute to slower biological aging in older adults, according to a new study.
-
News58% of patients affected by 2022 mpox outbreak report lasting physical symptoms
A cohort study found that more than half of those diagnosed with mpox during the 2022 outbreak still had lingering physical effects 11 to 18 months later.